[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CL2015002688A1 - Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo. - Google Patents

Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo.

Info

Publication number
CL2015002688A1
CL2015002688A1 CL2015002688A CL2015002688A CL2015002688A1 CL 2015002688 A1 CL2015002688 A1 CL 2015002688A1 CL 2015002688 A CL2015002688 A CL 2015002688A CL 2015002688 A CL2015002688 A CL 2015002688A CL 2015002688 A1 CL2015002688 A1 CL 2015002688A1
Authority
CL
Chile
Prior art keywords
active agent
fine particulate
compositions
same
topical formulations
Prior art date
Application number
CL2015002688A
Other languages
English (en)
Inventor
Zahra Mansouri
Xin Chen
Rodica-Tatiana Canelide
Original Assignee
Lab Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015002688(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lab Skin Care Inc filed Critical Lab Skin Care Inc
Publication of CL2015002688A1 publication Critical patent/CL2015002688A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

UNA COMPOSICION DE RETINOIDE PARTICULADA SECA Y FINA QUE INCLUYE UNOS AGENTES ACTIVOS RETINOIDE PRESENTES DENTRO DE LOS POROS DE LAS PARTICULAS DE CALCIO NANOPOROSAS Y/O EN LA SUPERFICIE DE LAS PARTICULAS Y/O DEBILMENTE ASOCIADOS CON LAS PARTICULAS; SU METODO DE PRODUCCION; FORMULACION TOPICA QUE LA COMPRENDE; Y METODO PARA SUMINISTRAR UN AGENTE ACTIVO RETINOIDE A UN SUJETO.
CL2015002688A 2013-03-15 2015-09-14 Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo. CL2015002688A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798758P 2013-03-15 2013-03-15
US201461938080P 2014-02-10 2014-02-10

Publications (1)

Publication Number Publication Date
CL2015002688A1 true CL2015002688A1 (es) 2016-04-08

Family

ID=51528082

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002688A CL2015002688A1 (es) 2013-03-15 2015-09-14 Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo.

Country Status (16)

Country Link
US (5) US20140271879A1 (es)
EP (1) EP2968157B1 (es)
JP (1) JP2016514694A (es)
KR (1) KR20150131285A (es)
CN (2) CN105358135A (es)
AU (1) AU2014233420A1 (es)
BR (1) BR112015023117A2 (es)
CA (1) CA2906838A1 (es)
CL (1) CL2015002688A1 (es)
EA (1) EA201591826A1 (es)
ES (1) ES2975482T3 (es)
MX (1) MX366277B (es)
MY (1) MY183106A (es)
NZ (1) NZ713342A (es)
SG (1) SG11201507667SA (es)
WO (1) WO2014145034A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201406431QA (en) * 2008-09-23 2014-11-27 Lab Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
BR112015023117A2 (pt) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc composições de agente ativo retinóide particulado fino seco e formulações tópicas incluindo as mesmas
WO2016073529A1 (en) * 2014-11-03 2016-05-12 Stella & Dot Llc Skincare formulations and regimens
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CN113181073B (zh) * 2021-04-30 2022-12-23 广州市科能化妆品科研有限公司 一种复合维生素乳液、祛皱精华霜及其制备方法
WO2024045049A1 (en) * 2022-08-31 2024-03-07 L'oreal Composition for caring for keratin materials and mask containing the same
CN115820338A (zh) * 2023-02-22 2023-03-21 中国科学院昆明植物研究所 一种脱臭青刺果油的制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
FR2717686B1 (fr) * 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Composition dermo-cosmétologique et procédé de préparation.
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
FR2774907B1 (fr) * 1998-02-19 2000-05-12 Luc Dewandre Nouvelle formulation topique a base de retinaldehyde
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
WO2005037267A1 (ja) * 2003-10-15 2005-04-28 Ltt Bio-Pharma Co., Ltd. 多価金属無機塩被覆レチノイン酸ナノ粒子の粒径の調整方法および当該調整方法により得られたナノ粒子
KR20100111311A (ko) * 2008-01-30 2010-10-14 티비씨 그룹 컴퍼니 리미티드 피부 외용 조성물 및 미백 화장료
SG10201406431QA (en) * 2008-09-23 2014-11-27 Lab Skin Care Inc Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
WO2010050980A1 (en) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
CA2760945A1 (en) * 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US9095510B2 (en) * 2009-11-10 2015-08-04 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
BR112015023117A2 (pt) * 2013-03-15 2017-07-18 Laboratory Skin Care Inc composições de agente ativo retinóide particulado fino seco e formulações tópicas incluindo as mesmas
WO2019068096A1 (en) * 2017-09-29 2019-04-04 Rodan & Fields, Llc COMPOSITIONS CONTAINING RETINALDEHYDE AND METHODS OF USE

Also Published As

Publication number Publication date
ES2975482T3 (es) 2024-07-08
US20160317469A1 (en) 2016-11-03
EA201591826A1 (ru) 2016-01-29
WO2014145034A1 (en) 2014-09-18
CA2906838A1 (en) 2014-09-18
NZ713342A (en) 2020-12-18
US20210259991A1 (en) 2021-08-26
EP2968157A1 (en) 2016-01-20
US20200222336A1 (en) 2020-07-16
EP2968157B1 (en) 2023-11-08
US20180028469A1 (en) 2018-02-01
MY183106A (en) 2021-02-15
SG11201507667SA (en) 2015-10-29
BR112015023117A2 (pt) 2017-07-18
CN112263549A (zh) 2021-01-26
MX366277B (es) 2019-07-04
EP2968157A4 (en) 2016-12-14
KR20150131285A (ko) 2015-11-24
AU2014233420A1 (en) 2015-11-12
CN105358135A (zh) 2016-02-24
MX2015013254A (es) 2016-04-15
JP2016514694A (ja) 2016-05-23
US20140271879A1 (en) 2014-09-18
AU2014233420A8 (en) 2015-11-26

Similar Documents

Publication Publication Date Title
CL2015002688A1 (es) Composiciones de agente activo retinoide particulado fino en seco, formulaciones tópicas incluyendo el mismo.
IL277385A (en) Combinations of decitabine derivatives and other active substances, kits and preparations containing them and their uses
AR097901A1 (es) Agente beneficioso con partículas de administración
BR112016007375A2 (pt) conjuntos de procedimentos para habilitar comunicações sem fio com o uso de estruturas de subquadro que tenham diferentes durações de subquadro
CL2017000240A1 (es) Compuestos activos hacia bromodominios
CL2016001547A1 (es) Composiciones para el cuidado oral
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
CL2016000298A1 (es) Compuestos derivados de tieno[2,3-c]piran con actividad moduladora del regulador de la conductancia transmembrana de la fibrosis quistica (cftr); composicion farmaceutica que los comprende; utiles en el tratamiento de la fibrosis quistica.
UY35281A (es) Composiciones que incluyen agentes para conferir carácter hidrofóbico y estabilizantes y métodos para elaborar y usar los mismos
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
UY34617A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas
CL2016000508A1 (es) Compuestos derivados de (2-metil-3-fenilfenil)metoxi sustituidos, inhibidores de la interacción pd-1/proteína pd-l1/proteína; composición farmacéutica que los comprende; y su uso para tratar una enfermedad infecciosa o cáncer.
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
UY34636A (es) Composiciones tópicas que comprenden fipronilo y permetrina y sus métodos de uso
MY177921A (en) Elimination agent for oral cavity biofilm and oral cavity composition
PE20151759A1 (es) Imidazopiridazinas sustituidas
DOP2016000007A (es) Pirazolpiridinas sustituidas
BR112016011742A2 (pt) Composição de limpeza com rápido colapso de espuma
MX2015012293A (es) Derivados piridin-4-ilo.
BR112017016483A2 (pt) encapsulamento de agentes ativos de potência alta
CL2015002161A1 (es) Composiciones no acuosas para el cuidado bucal.
CL2015002470A1 (es) Composición para formar una estructura porosa absorbente
CL2016001546A1 (es) Composición para el cuidado oral que comprende serina y al menos una sal de zinc.